Guonan Zhang

5PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 16, 2024
All-trans Retinoic Acid Sensitizes Epithelial Ovarian Cancer to PARP Inhibition after Exposure to Cisplatin.

Bingjie Mei, Junyang Li, Dengfeng Wang

|Nov 25, 2022
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial).

Xinyu Qu, Junjun Qiu, Lili Jiang

|Nov 01, 2022
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity.

Jianmei Huang, Meiying Li, Bingjie Mei

|Mar 27, 2021
Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study.

Dengfeng Wang, Guonan Zhang, Chunrong Peng

|Mar 22, 2021
The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials.

Xin-Ru Li, Yi Zhu, Guo-Nan Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Jianming Huang

2 joint publications

Dengfeng Wang

1 joint publications

Xin-Ru Li

1 joint publications

Yi Zhu